Rafferty Asset Management’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.66M | Buy |
|
|||||
|
2025
Q2 | $1.8M | Sell |
|
|||||
|
2025
Q1 | $3.17M | Buy |
|
|||||
|
2024
Q4 | $4.03M | Sell |
|
|||||
|
2024
Q3 | $4.45M | Buy |
|
|||||
|
2024
Q2 | $3.33M | Sell |
|
|||||
|
2024
Q1 | $8.88M | Sell |
|
|||||
|
2023
Q4 | $10.7M | Sell |
|
|||||
|
2023
Q3 | $8.45M | Buy |
|
|||||
|
2023
Q2 | $2.39M | Sell |
|
|||||
|
2023
Q1 | $3M | Sell |
|
|||||
|
2022
Q4 | $4.6M | Buy |
|
|||||
|
2022
Q3 | $1.84M | Buy |
|
|||||
|
2022
Q2 | $1.11M | Buy |
|
|||||
|
2022
Q1 | $742K | Sell |
|
|||||
|
2021
Q4 | $6.77M | Buy |
|
|||||
|
2021
Q3 | $1.56M | Buy |
|